The Eli and Edythe Broad Foundation will be making three gifts totaling $30 million to fund innovative research, faculty recruitment, training, and retention at The Broad Foundation’s namesake stem cell research centers at UCSF, the UCLA and the USC.
Unlike other gene mutations linked to autism, which are thought to alter brain development before birth, the newly identified changes in brain signaling may occur closer to the onset of autism symptoms in the first years of life.
The Third Street Garage across from the new Chase Center will soon be transformed into a visually stimulating anchor structure, complementing the rapidly changing Mission Bay neighborhood and amplifying UCSF’s scientific brand.
UCSF is opening a pioneering cancer center devoted to providing adult patients with highly advanced treatments, including immunotherapy, genetic counseling, molecular profiling of tumors, fully integrated clinical trials, and advanced imaging.
UCSF Health is opening a pioneering Precision Cancer Medicine Building devoted to bringing together the leading science with patient-centered care to provide patients with the most advanced, personalized treatments.
A Phase 3 study has found that patients with Sickle Cell Disease (SCD) who took a daily dose of the novel drug voxelotor had less anemia and made healthier red blood cells than patients receiving a placebo.
Research identifies enzymes produced by two different bacterial species that work together to digest L-Dopa in the human gut. Blocking one of these bacterial enzymes could significantly boost the drug’s efficacy in these patients.